![]() | Seguin-Devaux, C., BRANDUS, B., PLESSERIA, J.-M., Iserentant, G., Servais, J.-Y., Pitiot, A., Kanli, G., BEHRMANN, I., Schober, R., ZIMMER, J., Cohen, J. H. M., & DERVILLEZ, X. (2025). Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer. ImmunoTargets and Therapy, 14, 979 - 995. doi:10.2147/ITT.S517584 Peer Reviewed verified by ORBi |
![]() | Pogorelov, D., Bode, S. F. N., HE, X., Ramiro-Garcia, J., Hedin, F., Ammerlaan, W., Konstantinou, M., Capelle, C. M., Zeng, N., POLI, A., Domingues, O., Montamat, G., Hunewald, O., Ciré, S., BARON, A., LONGWORTH, J., Demczuk, A., Bazon, M. L., Casper, I., ... OLLERT, M. (26 November 2024). Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study. Nature Communications, 15 (1), 10266. doi:10.1038/s41467-024-54684-2 Peer Reviewed verified by ORBi |
![]() | Poli, A., Oudin, A., Muller, A., Salvato, I., Scafidi, A., Hunewald, O., Domingues, O., NAZAROV, P., Puard, V., Baus, V., AZUAJE, F., DITTMAR, G., ZIMMER, J., MICHEL, T., MICHELUCCI, A., NICLOU, S. P., & OLLERT, M. (March 2023). Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice. Allergy, 78 (3), 682-696. doi:10.1111/all.15545 Peer Reviewed verified by ORBi |
![]() ![]() | WILMES, P., ZIMMER, J., Schulz, J., Glod, F., Veiber, L., MOMBAERTS, L., Rodrigues, B., AALTO, A., Pastore, J., Snoeck, C. J., OLLERT, M., FAGHERAZZI, G., MOSSONG, J., GONCALVES, J., SKUPIN, A., & NEHRBASS, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056 Peer Reviewed verified by ORBi |
![]() | BAGINSKA, J., VIRY, E., BERCHEM, G. J. M. J., Poli, A., Noman, M. Z., van Moer, K., Medves, S., ZIMMER, J., Oudin, A., NICLOU, S. P., Bleackley, R. C., Goping, I. S., Chouaib, S., & JANJI, B. (22 October 2013). Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 110 (43), 17450-5. doi:10.1073/pnas.1304790110 Peer Reviewed verified by ORBi |